1/ #BRCAbrief #BRCA
Personalizing treatment decisions in early #breastcancer w/ Terry Mamounas, MD, @DrSGraff, & @KellyKhunt
Supported by educational grants from AstraZeneca Pharmaceuticals and Merck Sharp & Dohme LLC.
CME ℹ️ bit.ly/3Q51Wqn
📊 What is your specialty/degree❓
25%
Surgical MD/DO
0%
Surgical NP/PA
75%
Medical Oncologist
0%
Other
8 votes • Final results
1
1
2,148
2/ How do you integrate adjuvant treatment for germline #BRCA carriers w/ HER2-negative early #breastcancer❓
#BRCAbrief
2
3
6
1,256
3/ 👩 Beth is a 38-year-old female w/ BRCA1+ grade 3 TNBC & residual disease after NACT + pembro
📊 Which adjuvant therapy would you select❓
#BRCABrief #BRCA
0%
Talazoparib
7%
Pembro
7%
Pembro + capecitabine
87%
Olaparib,consider prembro
15 votes • Final results
2
1
398
4/ 💬 How does germline #BRCA testing impact treatment choices in early #breastcancer❓
🎥 Terry Mamounas, MD will provide his experience & expertise in the video below! #BRCABrief
Feb 5, 2025 · 10:00 PM UTC
1
2
376
5/ 👩 Beth is a 38-year-old female w/ BRCA1+ grade 3 TNBC & residual disease after NACT + pembro
📊 Which adjuvant therapy would you select❓
#BRCABrief #BRCA
0%
Talazoparib
7%
Pembro
29%
Pembro + capecitabine
64%
Olaparib,consider prembro
14 votes • Final results
2
1
1
428
6/ We hope you enjoyed this #BRCAbrief!
Complete the posttest & evaluation here 👉 bit.ly/4aLyVtg
& claim your 🆓 CME!
🗓️ See you for our next #breastcancer #BRCA brief w/ Terry Mamounas, MD, @DrSGraff, & @KellyKhunt
1
1
1,877